Literature DB >> 8078056

Myeloma: the role of interleukin 6.

L Russell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8078056      PMCID： PMC1294063          DOI： 10.1177/014107689308600824

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  6 in total

1.  Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6.

Authors:  B Klein; X G Zhang; M Jourdan; J Content; F Houssiau; L Aarden; M Piechaczyk; R Bataille
Journal:  Blood       Date:  1989-02       Impact factor: 22.113

2.  Interleukin-6 is a potent myeloma-cell growth factor in patients with aggressive multiple myeloma.

Authors:  X G Zhang; B Klein; R Bataille
Journal:  Blood       Date:  1989-07       Impact factor: 22.113

Review 3.  Plasma cell myeloma--new biological insights and advances in therapy.

Authors:  B Barlogie; J Epstein; P Selvanayagam; R Alexanian
Journal:  Blood       Date:  1989-03       Impact factor: 22.113

Review 4.  The biology of multiple myeloma.

Authors:  B G Durie
Journal:  Hematol Oncol       Date:  1988 Apr-Jun       Impact factor: 5.271

5.  Heterogeneity in response to interleukin 6 (IL-6), expression of IL-6 and IL-6 receptor mRNA in a panel of established human multiple myeloma cell lines.

Authors:  H Jernberg; M Pettersson; T Kishimoto; K Nilsson
Journal:  Leukemia       Date:  1991-03       Impact factor: 11.528

6.  Interleukin 3 and interleukin 6 synergistically promote the proliferation and differentiation of malignant plasma cell precursors in multiple myeloma.

Authors:  L Bergui; M Schena; G Gaidano; M Riva; F Caligaris-Cappio
Journal:  J Exp Med       Date:  1989-08-01       Impact factor: 14.307
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.